METHYLATROPINE: 15 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
15
Total FAERS Reports
0
Deaths Reported
14
Hospitalizations
15
As Primary/Secondary Suspect
9
Life-Threatening
Active Ingredient: METHYLATROPINE NITRATE ·
First Report: 20081219 · Latest Report: 20081219
What Are the Most Common METHYLATROPINE Side Effects?
#1 Most Reported
Toxicity to various agents
13 reports (86.7%)
#2 Most Reported
Sedation complication
13 reports (86.7%)
#3 Most Reported
Sedation
13 reports (86.7%)
All METHYLATROPINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Balance disorder | 13 | 86.7% | 0 | 12 |
| Blood calcium decreased | 13 | 86.7% | 0 | 12 |
| Cognitive disorder | 13 | 86.7% | 0 | 12 |
| Constipation | 13 | 86.7% | 0 | 12 |
| Creatinine renal clearance decreased | 13 | 86.7% | 0 | 12 |
| Depressed level of consciousness | 13 | 86.7% | 0 | 12 |
| Fall | 13 | 86.7% | 0 | 12 |
| Hypotension | 13 | 86.7% | 0 | 12 |
| Mobility decreased | 13 | 86.7% | 0 | 12 |
| Orthostatic hypotension | 13 | 86.7% | 0 | 12 |
| Pain | 13 | 86.7% | 0 | 12 |
| Sedation | 13 | 86.7% | 0 | 12 |
| Sedation complication | 13 | 86.7% | 0 | 12 |
| Toxicity to various agents | 13 | 86.7% | 0 | 12 |
| Drug interaction | 10 | 66.7% | 0 | 9 |
| Dyspnoea | 10 | 66.7% | 0 | 9 |
| Multiple drug therapy | 10 | 66.7% | 0 | 9 |
| Renal function test abnormal | 10 | 66.7% | 0 | 9 |
| Overdose | 5 | 33.3% | 0 | 4 |
Who Reports METHYLATROPINE Side Effects? Age & Gender Data
Gender: 100.0% female, 0.0% male. Average age: 59.3 years. Most reports from: CA. View detailed demographics →
Is METHYLATROPINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2008 | 2 | 0 | 2 |
What Is METHYLATROPINE Used For?
| Indication | Reports |
|---|---|
| Angina pectoris | 7 |
| Coronary artery disease | 6 |
Official FDA Label for METHYLATROPINE
Official prescribing information from the FDA-approved drug label.